Durham, NC, United States of America

Eleonora Lad

This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eleonora Lad: Innovator in Age-Related Macular Degeneration Detection

Introduction

Eleonora Lad is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of medical technology, particularly in the detection of age-related macular degeneration. Her innovative work utilizes advanced machine learning techniques to improve diagnostic accuracy.

Latest Patents

Eleonora Lad holds a patent for "Systems and methods related to age-related macular degeneration." This patent describes systems that utilize machine learning to detect geographic atrophy. The system includes at least one processor, a memory, and a computing platform. It is designed to receive volumetric scan images, determine their positions, and generate a probabilistic likelihood that each scan is informative of geographic atrophy or neovascular age-related macular degeneration. The system can identify high probability scans, assess the presence of these conditions, and output relevant information regarding their likelihood.

Career Highlights

Eleonora is affiliated with Duke University, where she continues her research and development in medical technologies. Her work has garnered attention for its potential to enhance patient outcomes through early detection and intervention.

Collaborations

Some of her notable coworkers include Cynthia A Toth and Lawrence L Carin, who contribute to her research efforts and advancements in the field.

Conclusion

Eleonora Lad's innovative contributions to the detection of age-related macular degeneration exemplify the impact of technology in healthcare. Her work not only advances medical diagnostics but also holds promise for improving the quality of life for patients affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…